| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $1.04 ▲ +4.00% | Yesterday | $1.11 ▼ -9.91% | Tomorrow's TScan Therapeutics Inc. Common Stock (TCRX) setup is anchored to $1.00 and targets $1.04 (+4.00%). The near-term read is upside; watch $1.05 / $0.9200 because daily realized volatility is about 6.05%. |
Tomorrow's TScan Therapeutics Inc. Common Stock (TCRX) setup is anchored to $1.00 and targets $1.04 (+4.00%). The near-term read is upside; watch $1.05 / $0.9200 because daily realized volatility is about 6.05%. | ||||
| Week | $1.11 ▲ +11.00% | Last Week | $1.26 ▼ -20.63% | The 7-day TScan Therapeutics Inc. Common Stock model moves from $1.26 to $1.11 (+11.00%). It gives upside momentum context for this stock, so breaks around $1.05 / $0.9200 matter more than a single tick. |
The 7-day TScan Therapeutics Inc. Common Stock model moves from $1.26 to $1.11 (+11.00%). It gives upside momentum context for this stock, so breaks around $1.05 / $0.9200 matter more than a single tick. | ||||
| Month | $1.20 ▲ +20.00% | Last Month | $1.19 ▼ -15.97% | The 1-month TScan Therapeutics Inc. Common Stock target is $1.20 (+20.00%), compared with the live reference near $1.00. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month TScan Therapeutics Inc. Common Stock target is $1.20 (+20.00%), compared with the live reference near $1.00. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $1.30 ▲ +30.00% | Last Year | $1.24 ▼ -19.35% | The 1-year TScan Therapeutics Inc. Common Stock scenario points to $1.30 (+30.00%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year TScan Therapeutics Inc. Common Stock scenario points to $1.30 (+30.00%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $1.54 ▲ +54.00% | 5 Years Ago | $10.50 ▼ -90.48% | The 5-year TScan Therapeutics Inc. Common Stock view is $1.54 (+54.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year TScan Therapeutics Inc. Common Stock view is $1.54 (+54.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 3.4 | Bearish |
| MACD | 0.09 | Bullish |
| SMA 50 | $1.12 | Mid |
| SMA 200 | $2.18 | Mid |
| EMA 20 | $2.70 | Mid |
| Opening Price | $1.08 | Start Date | 2021-07-16 |
| Day Range | $1.00 – $1.10 | Market Cap | $76.33M |
| Monthly Range | $1.00 – $1.43 | 24h Volume | n/a |
| 90D Range | $0.9104 – $1.43 | Circulating | n/a |
| 52W Range | $0.8957 – $4.85 | Max Supply | n/a |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.